References

Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas

10.1016/j.diabres.2019.107843 · 2019 · External reference

Prevalence of diabetes in India: A review of IDF diabetes atlas 10th edition

10.2174/1573399819666230413094200 · 2024 · External reference

IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045

10.1016/j.diabres.2021.109119 · 2022 · External reference

The global burden of type 2 diabetes attributable to tobacco: a secondary analysis from the global burden of disease study 2019

10.3389/fendo.2022.905367 · 2022 · External reference

Age-related disparities in diabetes risk attributable to modifiable risk factor profiles in Chinese adults: a nationwide, population-based, cohort study

10.1016/s2666-7568(21)00177-x · 2021 · External reference

Prevalence of diabetes, pre-diabetes and associated risk factors: second National Diabetes Survey of Pakistan (NDSP), 2016–2017

10.1136/bmjopen-2017-020961 · 2018 · External reference

Type 2 diabetes

10.1016/s0140-6736(17)30058-2 · 2017 · External reference

Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention

10.7150/ijms.10001 · 2014 · External reference

Incidence and trends of childhood type 1 diabetes worldwide 1990–1999

10.1111/j.1464-5491.2006.01925.x · 2006 · External reference

Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study

10.1016/s0140-6736(09)60568-7 · 2009 · External reference

Genetic susceptibility, obesity and lifetime risk of type 2 diabetes: The ARIC study and Rotterdam Study

10.1111/dme.14639 · 2021 · External reference

Management of type 2 diabetes in developing countries: balancing optimal glycaemic control and outcomes with affordability and accessibility to treatment

10.1007/s13300-019-00733-9 · 2020 · External reference

IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045

10.1016/j.diabres.2018.02.023 · 2018 · External reference

Global estimates of diabetes prevalence for 2013 and projections for 2035

10.1016/j.diabres.2013.11.002 · 2014 · External reference

Unresolved reference

External reference

Type 2 Diabetes Mellitus(T2DM) in Pakistan: Prevalence, Trends and Management Strategies

10.21649/akemu.v28i2.5117 · 2022 · External reference

Type 2 diabetes mellitus in Pakistan: Current prevalence and future forecast

2016 · External reference

Pattern of physical activity among persons with type 2 diabetes with special consideration to daily routine

2016 · External reference

Diabetes and its associated factors: A Retrospective cohort analysis of a large database at Indus Hospital Health Network

2024 · External reference

Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in Chinese rural residents: a cross-sectional survey

10.1038/s41598-019-46857-7 · 2019 · External reference

Syndemics at play: chronic kidney disease, diabetes and COVID-19 in Pakistan

10.1080/07853890.2021.1910335 · 2021 · External reference

Epidemiology of diabetes and diabetes-related complications

10.2522/ptj.20080020 · 2008 · External reference

Socioeconomic inequalities in mortality, morbidity and diabetes management for adults with type 1 diabetes: a systematic review

10.1371/journal.pone.0177210 · 2017 · External reference

Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research

10.4239/wjd.v6.i13.1246 · 2015 · External reference

Diabetic nephropathy: recent advances in pathophysiology and challenges in dietary management

10.1186/s13098-019-0403-4 · 2019 · External reference

Prevalence of Diabetic retinopathy and its associated factors among diabetic patients at Debre Markos referral hospital, Northwest Ethiopia, 2019: hospital-based cross-sectional study

10.2147/dmso.s260694 · 2020 · External reference

Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1· 9 million people

10.1016/s2213-8587(14)70219-0 · 2015 · External reference

Diagnosis and classification of diabetes mellitus

10.2337/diacare.29.s1.06.s43 · 2006 · External reference

Fighting diabetes mellitus: Pharmacological and non-pharmacological approaches

10.2174/1381612826666200728144200 · 2020 · External reference

The effect of diabetes self-management education on body weight, glycemic control, and other metabolic markers in patients with type 2 diabetes mellitus

10.1155/2014/789761 · 2014 · External reference

A systematic review: family support integrated with diabetes self-management among uncontrolled type II diabetes mellitus patients

10.3390/bs7030062 · 2017 · External reference

Diabetes self-management education and support in type 2 diabetes: a joint position statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics

10.2337/dc15-0730 · 2015 · External reference

Significance of HbA1c test in diagnosis and prognosis of diabetic patients

10.4137/bmi.s38440 · 2016 · External reference

Self-management based coaching program to improve diabetes mellitus self-management practice and metabolic markers among uncontrolled type 2 diabetes mellitus in Indonesia: A quasi-experimental study

10.1016/j.dsx.2019.12.002 · 2020 · External reference

Monotherapy in patients with type 2 diabetes mellitus

10.4093/dmj.2017.41.5.349 · 2017 · External reference

Pathophysiologic approach to therapy in patients with newly diagnosed type 2 diabetes

10.2337/dcs13-2011 · 2013 · External reference

Utilization of some newer oral antidiabetic agents in a tertiary care hospital

10.5455/njppp.2012.2.146-151 · 1970 · External reference

National trends in anti-diabetic treatment in Taiwan, 2000–2009

10.1016/j.jfma.2012.09.009 · 2012 · External reference

The prescribing trend of oral antidiabetic agents for type 2 diabetes in Taiwan: an 8-year population-based study

2017 · External reference

Patterns of anti‐diabetic medication use in patients with type 2 diabetes mellitus in England and Wales

10.1002/pds.4092 · 2017 · External reference

Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second‐line therapy after metformin monotherapy: R etrospective data for 10 256 individuals from the U nited K ingdom and G ermany

10.1111/dom.13083 · 2018 · External reference

Erratum. Pharmacologic Approaches to Glycemic Treatment. Sec. 8. In Standards of Medical Care in Diabetes—2017

2017 · External reference

9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes—2019

10.2337/dc19-s009 · 2019 · External reference

9. Pharmacologic approaches to glycemic treatment: Standards of Medical Care in Diabetes—2020

10.2337/dc20-s009 · 2020 · External reference

Update on insulin therapy for type 2 diabetes

10.1210/jc.2011-2202 · 2012 · External reference

Response to Comments on Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

2015 · External reference

Impact of pharmacist-led diabetes self-care education on patients with type 2 diabetes in Pakistan: a randomized controlled trial

10.3389/fphar.2022.754999 · 2022 · External reference

IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040

10.1016/j.diabres.2017.03.024 · 2017 · External reference

Loss of glycemic control in patients with type 2 diabetes mellitus who were receiving initial metformin, sulfonylurea, or thiazolidinedione monotherapy

10.1592/phco.27.8.1102 · 2007 · External reference

Secondary failure rates associated with metformin and sulfonylurea therapy for type 2 diabetes mellitus

10.1592/phco.2005.25.6.810 · 2005 · External reference

Benefits and pitfalls of using insulin in the management of type 2 diabetes patients: a clinical evaluation

2014 · External reference

Insulin therapy for type 2 diabetes mellitus

10.1001/jama.2014.5951 · 2014 · External reference

Comparative evaluation of biphasic insulin with metformin and triple oral hypoglycemic agents (OHA) in type 2 diabetes patients

10.1016/j.jsps.2019.11.023 · 2020 · External reference

The market in diabetes

10.1007/s00125-005-0108-0 · 2006 · External reference

Comparison of efficacy and safety of basal and premixed insulin regimens among Type II diabetes patients transiting from oral agents to insulin

2013 · External reference

Systematic review: comparative effectiveness and safety of premixed insulin analogues in type 2 diabetes

10.7326/0003-4819-149-8-200810210-00242 · 2008 · External reference

Insulin-based versus triple oral therapy for newly diagnosed type 2 diabetes: which is better?

10.2337/dc09-0653 · 2009 · External reference

Association between insulin monotherapy versus insulin plus metformin and the risk of all-cause mortality and other serious outcomes: a retrospective cohort study

10.1371/journal.pone.0153594 · 2016 · External reference

Prevalence and incidence of hypoglycaemia in 532,542 people with type 2 diabetes on oral therapies and insulin: a systematic review and meta-analysis of population based studies

10.1371/journal.pone.0126427 · 2015 · External reference

Insulin adherence in type 2 diabetes in Mexico: behaviors and barriers

10.1155/2018/3190849 · 2018 · External reference

Insulin monotherapy versus insulin combined with other glucose-lowering agents in type 2 diabetes: a narrative review

10.5812/ijem.65600 · 2018 · External reference

Polypharmacy in elderly patients with type 2 diabetes receiving oral antidiabetic treatment

10.1007/s00592-015-0790-4 · 2016 · External reference

Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial

2009 · External reference

Metformin: Mechanisms in Human Obesity and Weight Loss

10.1007/s13679-019-00335-3 · 2019 · External reference

Empagliflozin as add-on to metformin in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial

10.2337/dc13-2105 · 2014 · External reference

Insulin-associated weight gain in obese type 2 diabetes mellitus patients: What can be done?

10.1111/dom.13009 · 2017 · External reference

Efficacy and safety of treatment with quadruple oral hypoglycemic agents in uncontrolled type 2 diabetes mellitus: a multi-center, retrospective, observational study

10.4093/dmj.2020.0107 · 2021 · External reference

Rising cost of insulin: A deterrent to compliance in patients with diabetes mellitus

10.1016/j.dsx.2022.102528 · 2022 · External reference